SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21147946
Source:
http://linkedlifedata.com/resource/pubmed/id/21147946
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0018099
,
umls-concept:C0022661
,
umls-concept:C0030705
,
umls-concept:C0403447
,
umls-concept:C1273870
pubmed:issue
12
pubmed:dateCreated
2010-12-14
pubmed:abstractText
Many patients with gout have comorbidities, including hypertension and chronic kidney disease (CKD). The goals when treating gout are no different in these patients, but the choice and dosage of drugs may need to be modified.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21147946
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21147946-21370528
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8703441
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones
,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenocorticotropic Hormone
,
http://linkedlifedata.com/resource/pubmed/chemical/Allopurinol
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...
,
http://linkedlifedata.com/resource/pubmed/chemical/Colchicine
,
http://linkedlifedata.com/resource/pubmed/chemical/Gout Suppressants
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/febuxostat
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1939-2869
pubmed:author
pubmed-author:El-ZawawyHossamH
,
pubmed-author:MandellBrian FBF
pubmed:issnType
Electronic
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
919-28
pubmed:meshHeading
pubmed-meshheading:21147946-Adrenal Cortex Hormones
,
pubmed-meshheading:21147946-Adrenocorticotropic Hormone
,
pubmed-meshheading:21147946-Allopurinol
,
pubmed-meshheading:21147946-Anti-Inflammatory Agents, Non-Steroidal
,
pubmed-meshheading:21147946-Colchicine
,
pubmed-meshheading:21147946-Comorbidity
,
pubmed-meshheading:21147946-Disease Progression
,
pubmed-meshheading:21147946-Gout
,
pubmed-meshheading:21147946-Gout Suppressants
,
pubmed-meshheading:21147946-Humans
,
pubmed-meshheading:21147946-Kidney Failure, Chronic
,
pubmed-meshheading:21147946-Risk Factors
,
pubmed-meshheading:21147946-Thiazoles
pubmed:year
2010
pubmed:articleTitle
Managing gout: how is it different in patients with chronic kidney disease?
pubmed:affiliation
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Weston, FL, USA.
pubmed:publicationType
Journal Article
,
Review